tradingkey.logo

Bone Biologics Corp

BBLG
查看詳細走勢圖
1.630USD
0.0000.00%
交易中 美東報價延遲15分鐘
2.93M總市值
虧損本益比TTM

Bone Biologics Corp

1.630
0.0000.00%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

-5.23%

1月

+5.84%

6月

-40.29%

今年開始到現在

+12.41%

1年

-75.53%

查看詳細走勢圖

TradingKey Bone Biologics Corp股票評分

單位: USD 更新時間: 2026-02-02

操作建議

Bone Biologics Corp當前公司基本面數據相對非常健康,增長潛力很大。當前估值合理,在生物技術與醫療研究行業排名240/393位。機構持股佔比非常高,近一月多位分析師給出公司評級為。最高目標價為22.25。中期看,股價處於下降通道。近一個月,市場表現較強,基本面評分較高,但較強的走勢沒有得到技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Bone Biologics Corp評分

相關信息

行業排名
240 / 393
全市場排名
516 / 4529
所屬行業
生物技術與醫療研究

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Bone Biologics Corp亮點

亮點風險
Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
利潤高增長
公司淨利潤處於行業前列,最新年度總收入0.00美元
估值低估
公司最新PE估值-0.69,處於3年歷史低位

分析師目標

基於 0 分析師
--
評級
22.250
目標均價
+1256.71%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Bone Biologics Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Bone Biologics Corp簡介

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
公司代碼BBLG
公司Bone Biologics Corp
CEOFrelick (Jeffrey)
網址https://www.bonebiologics.com/
KeyAI